Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Nmc Health Plc LSE:NMC London Ordinary Share GB00B7FC0762 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -59.00p -2.50% 2,299.00p 2,303.00p 2,305.00p 2,334.00p 2,266.00p 2,334.00p 630,905 16:35:14
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 2,057.3 256.9 119.6 19.2 4,798.34

Nmc Health Share Discussion Threads

Showing 576 to 598 of 875 messages
Chat Pages: 35  34  33  32  31  30  29  28  27  26  25  24  Older
DateSubjectAuthorDiscuss
20/8/2018
09:33
LONDON - (Sharecast News) - NMC Health plumped earnings 30% in the first half of the year as the Gulf private healthcare operator's margins accelerated faster than revenues, boosted by acquisitions of a cosmetic surgery business and a chronic care specialist.Management said the financial and operational performance in the half-year was in line with expectations, with a "positive outlook" for the rest of 2018 after strong margin and the potential for guidance to be upgraded.Revenues of $932m were generated in the six months to 30 June, up 20.2% on the same period last year, with organic growth accounting for 13.4% of this growth.The healthcare division, which operates hospitals and specialist clinics from NMC's United Arab Emirates base and across 15 nearby countries, grew revenues 25.8% to $706.0m and EBITDA by 34.0% to $226.8m as EBITDA margins widened 190bps to 32.1%.Patient numbers increased 19.7% to 3.4m in the half compared to the same period last year as operational beds increased 36% to 1,530 helped by the ramp-up of what will be NMC's largest hospital, NMC Royal Hospital in Khalifa City, Abu Dhabi. Further growth is eyed from the agreed joint venture in Saudi Arabia with Hassana Investment Company once it is completed.The division was surgically augmented by the acquisition of a 70% stake in CosmeSurge, the only institutionalised cosmetics business in the Gulf region, as well as the acquisition of Chronic Care Specialist Medical Centre and outstanding minorities across several subsidies, particularly Fakih In Vitro Fertilisation unit. Management plan to rapidly expand CosmeSurge's clinics alongside NMC's existing healthcare network, which is expected to "substantially" boost its growth and margins.Other augmentations have been made outside the Middle East, including a contract to operate and manage two hospitals in Kenya, the opening of an IVF clinic in Nairobi, acquisitions of IVF clinics in Sweden and Latvia, and the £10m purchase of Aspen Healthcare in the UK, which operates four private hospitals and five clinics.The smaller distribution division, which is a wholesaler of pharmaceutical goods, medical equipment, cosmetics and food, increased revenue 8.4% to $255.0m, alongside an improved EBITDA margin of 11.9%.For the group as a whole, margins increased by 220 basis points to 24.2%, enabling earnings before interest, tax, depreciation and amortisation to surge 32.1% to $225.5m.Earnings per share were increased 30.8% to $0.561 and adjusted EPS by 30.2% to $0.669. No interim dividend was declared but a final dividend was indicated, in line with the policy to target a payout ratio of 20-30% of profit after tax.Chief executive Prasanth Manghat said: "The benefits of scale, our mix of healthcare verticals and cross utilisation of assets and business streams is now starting to be reflected through enhanced revenue and improved efficiencies and margins."Backed by a strong balance sheet, which was boosted by April's $450m convertible bond, Manghat said he saw "continuing good growth potential across different parts of the group in 2019 and beyond and remain confident in the long-term prospects of the business".In light of the demand for the group's healthcare services, the ramp-up at key locations and bolt-on acquisitions, Manghat and his board colleagues are in the process of reviewing full year guidance, which had indicated 22% revenue growth and EBITDA around $465m, and said they would provide an update expected to be provided at the capital markets day in London on 22 October.
steeplejack
20/8/2018
08:54
Topped up on the news this morning
malcolmmm
20/8/2018
08:49
Proactive: NMC Health plc (LON:NMC) said it has a positive outlook for the rest of the year after delivering a jump in first-half earnings and revenues. The company, which provides healthcare in the United Arab Emirates, posted a 32.1% increase in earnings (EBITDA) to US$225.5mln for the first six months of the year as margins grew by 220 basis points to 24.2%. Revenues gained 20.2% to US$932.0mln, driven by a strong performance in its healthcare division, which operates hospitals around the UAE. The healthcare division, which accounted for 73% of group revenues, saw the number of patients rise by 19.7% to 3.4mln. The distribution division, which provides wholesale trading of pharmaceuticals, medical equipment, food and cosmetics, posted an 8.4% increase in revenue to US$225mln.
aishah
20/8/2018
07:11
The report looks good
daijavu
18/8/2018
16:55
Results on Monday hope all is ok...
johnthespacer
16/8/2018
22:18
Take a look at acso - similar growth wise - companies like these and BUR are top notch
panic investor
16/8/2018
20:33
lovely looking chart but a p/e of 44 means the share price would drop lik a stone if the profits ever come in below expectations . Not sure why the dividend os so small !
arja
09/8/2018
17:37
ralphmalph 9 Aug '18 - 09:18 - 567 of 569 oh yeah, my mistake sorry John
mattyd
09/8/2018
10:27
5 year chart - a thing of beauty. Alas I haven't been a holder for five years.
brahmsnliszt
09/8/2018
09:50
Above 40 :-)
panic investor
09/8/2018
09:18
It most certainly is a FTSE100 Stock. It is number low fifties by market cap.
ralphmalph
08/8/2018
11:30
£40 today? Maybe
tdog1975
08/8/2018
11:23
its a FTSE250 not 100
mattyd
08/8/2018
11:01
The growth is stunning for a FTSE100. Who said elephants can't run? (I know, lol)
johnrxx99
06/8/2018
10:45
bought at 3476. It looks like it's continuing to climb
richard4796
14/7/2018
14:55
TMI very positive on Hassana deal. Says profit uplift could be $130mil and de-risks investment because of KSA Govt involved. Says Barenbergs new short term price target of £46 on 30x P/E. 5 year price target £100. Lovely stuff.
ralphmalph
12/7/2018
19:52
Time for a move up by the looks of it
panic investor
12/6/2018
10:26
Time for the next leg up here so I've bought a few more
volsung
11/6/2018
15:18
Oh it's good news alright but the current rating probably discounts solid news flow.Happy to hold.
steeplejack
11/6/2018
12:29
For 1 minute I didn't think anybody was going to post !
panic investor
11/6/2018
10:46
I agree it does look very interesting. Lots of money for top quality healthcare in Saudi. Should be very profitable.
ralphmalph
11/6/2018
10:00
This deal looks like a game changer for NMC and market beginning to factor in broker upgrades. Return to previous highs well underway. RM
rampmeister
04/6/2018
06:39
Check the chart - tracks the 20 week MA almost perfectly. Pullbacks have been great opportunities to top up in the past but sell volume this time is a bit concerning. Let's see what happens this week.
twistednik
Chat Pages: 35  34  33  32  31  30  29  28  27  26  25  24  Older
Your Recent History
LSE
NMC
Nmc Health
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190616 03:00:43